SCHEMBL5375915

SCHEMBL5375915

OB(OB(O)c1ccc(N(Cc2ccccc2)Cc2ccccc2)cc1)c1ccc(N(Cc2ccccc2)Cc2ccccc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 1/20 0.53
NR3C1 P04150 1/20 0.50
NR1H2 P55055 4/20 0.47
NR1H3 Q13133 4/20 0.47
TSHR P16473 3/20 0.46
CNR2 P34972 3/20 0.46
CYP2D6 P10635 2/20 0.40
TAAR1 Q96RJ0 2/20 0.40
LMNA P02545 2/20 0.40
CYP1A2 P05177 1/20 0.40
HTR1A P08908 1/20 0.40
ADRA2A P08913 1/20 0.40
ADORA3 P0DMS8 1/20 0.40
PDE6A P16499 1/20 0.40
ADRA2C P18825 1/20 0.40
MC4R P32245 1/20 0.40
ADRA1A P35348 1/20 0.40
HRH1 P35367 1/20 0.40
OPRM1 P35372 1/20 0.40
DRD3 P35462 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2320409 0.84 CYP2C19 (0.58) CYP2C19NR3C1NR1H2NR1H3TSHR
SCHEMBL2960872 0.79 CYP2C19 (0.78) CYP2C19NR3C1NR1H2NR1H3TSHR
SCHEMBL43183 0.74 TSHR (0.74) CYP2C19NR3C1NR1H2NR1H3TSHR
SCHEMBL2957378 0.74 CYP2C19 (0.64) CYP2C19NR3C1NR1H2NR1H3TSHR
SCHEMBL7154167 0.73 CYP2C19 (0.69) CYP2C19NR3C1NR1H2NR1H3TSHR
SCHEMBL2011193 0.73 CYP2C19 (0.69) CYP2C19NR3C1NR1H2NR1H3TSHR
SCHEMBL355040 0.72 TSHR (0.71) CYP2C19NR3C1NR1H2NR1H3TSHR
Hydrochloric Acid SCHEMBL2139953 0.72 TSHR (0.71) CYP2C19NR3C1NR1H2NR1H3TSHR
SCHEMBL1848691 0.72 TRPV6 (0.63) TSHRCYP1A2KMT2AGLAKDM4E
SCHEMBL3634273 0.72 CYP2C19 (0.62) CYP2C19NR3C1NR1H2NR1H3TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7196219-B2 Preparation of Anilineboronic acids and derivatives thereof ARCHIMICA GMBH (DE) 2007-03-27 US disclosed
EP-1479686-B1 Process for the preparation of aniline boronic acids and derivatives thereof ARCHIMICA GMBH (DE) 2006-10-04 EP disclosed
US-20050038287-A1 Preparation of Anilineboronic acids and derivatives thereof CLARIANT GMBH 2005-02-17 US disclosed
EP-1479686-A1 Process for the preparation of aniline boronic acids and derivatives thereof Clariant GmbH (DE) 2004-11-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050038287-A1 Preparation of Anilineboronic acids and derivatives thereof C9, BLVRB, CBR3 CYP2C19 202/4885NR3C1 409/4885NR1H2 667/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.